To conclude, we showed that melatonin treatment exerted a comprehensive and dose-dependent inhibitory effect on the proliferation and metastasis ability of BLCA cells by causing cell cycle arrest, inducing apoptosis, and suppressing AKT activity. The gene discussed is AKT1; the disease is bladder transitional cell carcinoma.